ArticleAmerican journal of translational research2020

Silencing miR-454 suppresses cell proliferation, migration and invasion via directly targeting MECP2 in renal cell carcinoma.

Huan Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.